Figure 3 of
Kay, Mol Vis 4:22, 1998.Figure 3 of
Kay, Mol Vis 4:22, 1998.
Figure 3. Immunofluorescent analysis of smooth muscle [alpha]-actin in CECs
CECs modulated with FGF-2 (10 ng/ml and 10 µg/ml heparin) were treated with inhibitors in the presence of FGF-2 for 24 h. Cells were stained with anti-smooth muscle [alpha]-actin antibody, processed and analyzed on confocal laser microscope as described in the text. (X 400)
(A) normal CECs
(B) cells treated with FGF-2
(C) cells treated with FGF-2 and LY294002 (20 µM)
(D) cells treated with FGF-2 and genistein (10 µM)
